How Atomo’s Pascal Cassette Fueled FebriDx’s FDA CLIA Waiver and US Market Boom

middle.news 9:38am on Monday 30th of March, 2026 AEDT • Healthcare Read Story

How Atomo’s Pascal Cassette Fueled FebriDx’s FDA CLIA Waiver and US Market Boom

9:38am on Monday 30th of March, 2026 AEDT Key Points FebriDx test receives FDA CLIA waiver, expanding US market 15-fold Atomo exclusively supplies Pascal cassettes integral to FebriDx performance Lumos’s US contract with PHASE Scientific worth up to US$313 million over six years Atomo’s supply agreement with Lumos runs through 2031 with committed volumes Read Story

middle. Tap to Read Tap the card to read the full analysis about ATOMO DIAGNOSTICS (ASX:AT1) OPEN ARTICLE